Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC
by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa
Updated on: May 23,2024
6

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC
by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa
Updated on:May 23,2024
6
